company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1706099.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2695130.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4401229.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4401229.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,642.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7476.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5726382.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5719548.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10120777.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10120777.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10120777.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10120777.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30700000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30700000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30228164.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q1,2010-09-01,2010-11-30,2012-01-06 16:11:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1126512.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3669246.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4795758.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4795758.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,356.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11756.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1810064.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1821464.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2974294.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2974294.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2974294.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2974294.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33000000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33000000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31778911.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q2,2010-12-01,2011-02-28,2012-04-09 15:38:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1733218.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3901651.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5634869.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5634869.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,486.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12116.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14643685.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14632055.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20266924.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20266924.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20266924.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20266924.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32700000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32700000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32594450.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q3,2011-03-01,2011-05-31,2012-07-10 15:37:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1612171.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4521973.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6134144.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6134144.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,516.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13652.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18589003.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18602139.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12467995.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12467995.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-16301000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3833005.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3833005.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32327000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2011.0,Q4,2011-06-01,2011-08-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5830000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6436000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12266000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12266000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,78000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2937000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2860000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15126000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15126000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,4904000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10222000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10222000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48084633.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2012.0,Q4,2012-06-01,2012-08-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6603000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6603000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,442000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,442000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6161000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8334000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6791000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15125000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8964000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2287000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6029000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8313000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17277000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17277000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17277000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17277000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59600000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59600000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59964308.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:25:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10248000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10248000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,786000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,786000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9462000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12372000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7759000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20131000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10669000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2744000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4803000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7405000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18202000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18202000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,6110000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12092000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12092000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57800000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57800000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57860366.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12134000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12134000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1314000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1314000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10820000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12064000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9547000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21611000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10791000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2979000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1146000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4094000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14885000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14891000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14891000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14891000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62000000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62000000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62118796.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 20:26:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16313000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16313000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,995000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,995000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15318000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13326000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11077000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24403000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9085000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3497000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-115000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3602000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12687000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12693000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12693000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12693000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63500000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63500000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62652079.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:13:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23764000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23764000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3917000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3917000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19847000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15077000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9001000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24078000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4231000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4380000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2557000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1809000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6040000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6031000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6031000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6031000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62896379.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:25:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17286000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17286000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3190000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3190000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14096000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16187000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13852000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30039000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15943000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3115000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,163000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2931000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18874000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18925000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18925000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18925000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63213504.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20453000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20453000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3722000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3722000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16731000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14839000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16552000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31391000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14660000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4498000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-531000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5002000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19662000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,21000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19683000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19683000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19683000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70300000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69140642.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 17:26:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23332000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23332000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2640000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2640000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20692000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17770000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11877000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29647000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8955000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4784000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-208000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4924000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13879000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,70000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13949000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13949000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13949000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82100000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82100000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,79771454.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:25:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25787000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25787000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2631000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2631000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23156000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19696000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14644000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34340000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11184000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3358000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-98000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3379000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14563000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14588000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14588000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14588000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,81000000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81000000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81290112.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 17:25:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24668000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24668000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3628000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3628000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21040000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19138000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15561000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34699000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13659000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3153000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,55000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3015000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16674000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,328000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17002000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17002000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17002000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78600000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78600000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78878500.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27470000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27470000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4331000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4331000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23139000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20388000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14019000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-14730000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,39600000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59277000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36138000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5018000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,132000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-213000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5099000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41237000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,348000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41585000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41585000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41585000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84900000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84900000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85255212.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q1,2016-01-01,2016-03-31,2016-05-05 17:26:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32045000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32045000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4948000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4948000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27097000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20864000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15685000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36549000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9452000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4322000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,126000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,179000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4017000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13469000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,550000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14019000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14019000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14019000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87600000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87600000.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85416542.0
Raptor Pharmaceutical Corp,RPTP,,0001070698,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 17:25:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
